Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-020924

Director disposed of 94,151 shares (other)

  • Director acquired 9,018 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tullman Stephen A. Director 2018-03-16 Other disposition −94,151 0 I
Tullman Stephen A. Director 2018-03-16 Other acquisition +9,018 130,807 D
Loading xslF345X03/doc4.xml…